IDH3A and glioma: In order to explore the correlation between ARG-related risk score and clinical features, we respectively compared the differences between the high- and low-risk groups in survival time, Glioma CpG island methylator phenotype (G-CIMP) status, gene expression subtype, isocitrate dehydrogenase (IDH) mutant status, etc. It was shown that the risk score did reveal a relationship with some clinical traits, especially in G_CIMP status and IDH mutant status (Figure 7).